Nevertheless, high FGFR2 expression assessed by these methods was reported to be associated with more aggressive clinical features including tumour depth, lymph node and distant metastases [49,50], and worse overall survival in patients with primary gastric [47] and GEJ cancers [49,50]. This evidence concerns the gene FGFR2 and neoplasm.